Folic Acid Supplement Prevents Phenytoin-Induced Gingival Hyperplasia
Researchers at the Division of Pediatric Neurology, Neurosciences Centre, New Delhi, India, performed a randomized, double-blind, placebo-controlled 6-month trial of oral folic acid supplement (0.5 mg/day) in children aged 6-15 years treated with phenytoin for epilepsy.
| 出版年: | Pediatric Neurology Briefs |
|---|---|
| 第一著者: | |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
Pediatric Neurology Briefs Publishers
2011-05-01
|
| 主題: | |
| オンライン･アクセス: | https://www.pediatricneurologybriefs.com/articles/632 |